Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Inks Agreements with Mount Sinai, CHOP Around Ingenuity Variant Analysis

Premium

Qiagen said this week that the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai School of Medicine has selected its Ingenuity Variant Analysis software solution for translational research applications around characterizing and identifying rare diseases.

In addition, the software will also be used for training purposes. Research scientists and medical students at the institute will also use Variant Analysis to analyze data from their own genomes.

Qiagen also announced that the Center for Applied Genomics at the Children's Hospital of Philadelphia has integrated Variant Analysis into a bioinformatics pipeline that it is using for a next-generation sequencing-based study that aims to identify causative variants in rare pediatric diseases.

The financial details of both agreements were not disclosed.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.